NEOGENOMICS INC — Director's Dealing 2020

Mar 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-03-02

Reporting Person: JONES STEVEN C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-02	Common Stock	S	250000	$28.85	Disposed	1375000	Indirect
2020-03-02	Common Stock	S	25000	$28.48	Disposed	125000	Indirect
2020-03-02	Common Stock	S	2300	$28.24	Disposed	40757	Indirect
2020-03-02	Common Stock	S	20000	$28.24	Disposed	30476	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	195234	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (125000.0)	125000	Indirect
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (100000.0)	100000	Indirect
Stock Option (Right to Buy)	$7.27	2022-05-25	Common Stock (10000.0)	10000	Direct
Stock Option (Right to Buy)	$11.6	2023-06-01	Common Stock (3017.0)	3017	Direct
Stock Option (Right to Buy)	$22.52	2026-06-06	Common Stock (4269.0)	4269	Direct

Footnotes

F1: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: On May 4, 2015, Mr. Jones was granted 225,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.